TREM1 and neoplasm: The results presented here allow us to draw two important conclusions: (1) HMGB1 induces activation of the TREM-1 pathway; (2) HMGB1 promotes activation of non-canonical cytotoxic T-lymphocytes capable of lysing HLA-negative tumor cells.